No abstract

No abstract

The antimicrobial activities of the methanol extract of Quercus ilex L. (Pirnal oak) leaves were tested in vitro against a wide range of human and plant-associated microorganisms. A total of 132 microbial organisms belonging to 55 bacteria and five fungi and yeast species were studied using a disc-diffusion method and microdilution assays. The results were evaluated as inhibition zones around the disc impregnated with Q. ilex extract at a concentration of 300 micro L/mL. The results showed that Q. ilex did not have any antifungal activities against Alterneria alternata, Aspergillus flavus, Fusarium oxysporum, Penicillum spp., whereas there were inhibition effects on the growth of all Candida albicans isolates. In total 97 bacterial strains (74%) were found to be resistant to Q. ilex extract. The remaining 35 (27%) strains of seven different bacteria genera including Brucella, Bacillus, Enterobacter, Neisseria, Pseudomonas and Escherichia were susceptible to the extract tested. The minimum inhibitory concentrations (MIC) of the extract ranged from 125 to 500 micro L/mL. These results suggest that Q. ilex possesses compounds with antibacterial and anticandidal properties.

No abstract

A series of some novel Ethyl 2-((1-hydroxynaphthalen-2-yl)methyleneamino)-5,6-dihydro-4H-cyclopenta[b]thiopehene-3-carboxylate, Ethyl 2-((1-hydroxynaphthalen-2-yl)methyleneamino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate, Ethyl 2-((1-hydroxynaphtalen-2-yl)methyleneamino)-5,6,7,8-tetrahydro-4H-cyclohepta [b]thiophene-3-carboxylate and their Cr(III) and Zn(II) complexes have been synthesized. All of these substances have been examined for antibacterial activity against pathogenic strains Listeria monocytogenes 4b (ATCC-19115), Staphylococcus aureus (ATCC25923), Proteus OX2 Wrah (ETS.40-A-4), Escherichia coli (ATCC-1280), Salmonella typhi H (NCTC-901.8394), Pseudomonas putida sp., Brucella abortus (A.99, UK-1995) RSKK-03026. Sh. boydii type 11 (Pasteur51.6), Sh. boydii type 16 (cHe 67.11), Sh. boydii type 6 (RSKK-96043), and antifungal activity against Candida albicans (Y-1200-NIH, Tokyo). Some of the compounds exhibited activity comparable to ampicillin ofloxacin, nystatin, kanamycin, sulphamethoxazol, amoxycillin, and chloroamphenicol. Most of the studied compounds were found effective against bacteria studied and yeast.